MXCT

MaxCyte, Inc.

Stock · NASDAQ

Program summary

FieldValueAs ofSource
Current authorization$10m30-Sep-2610-Q filed 10-Nov-26
Remaining authorization$5m30-Sep-2610-Q filed 10-Nov-26
Program expiry05-May-2730-Sep-2610-Q filed 10-Nov-26
Repurchased last quarter$4m30-Sep-2610-Q filed 10-Nov-26
Has used an ASRNo—

Programs

Authorized onAuthorizedRemainingExpiresTerms
12-May-26$10m$5m05-May-27All shares were repurchased pursuant to a $10 million repurchase authorized by our Board and publicly announced on May 12, 2026.10-Q filed 10-Nov-26

Open-market repurchases

Repurchased per month, USD (≈ shares × average price)
  1. ≈$4m
    Jul ’26
  2. Aug ’26
  3. ≈$0
    Sep ’26
Month endedSharesAvg price≈ ValueSource
30-Sep-260—$010-Q filed 10-Nov-26
31-Aug-260—$010-Q filed 10-Nov-26
31-Jul-262,947,468$1.36$4m10-Q filed 10-Nov-26
Filings through 30-Sep-26· checked 17-Nov-26